Skip to main content
ConductScienceScienceDex

Biediger, Ronald J

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #3,312
Unclaimed recordClaim profile
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$2.2M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#3,312
By linked amount among FY2023 PIs
Earliest Year Loaded
2022
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Biediger, Ronald J. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Biediger, Ronald J as a PI. Multi-PI records show the full award amount for context.

  • 2R42DK127869-02A1R42Contact PI
    Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD
    Aviara Pharmaceuticals, Inc.
    $1M
    award amount
  • 1R61HL168737-01R61Contact PI
    Targeting Integrin Signaling in Atherosclerosis
    Texas Heart Institute
    $572.1K
    award amount
  • 5R33HL161778-02R33Contact PI
    Optimization of small molecule integrin activators to enhance cord blood transplant
    Texas Heart Institute
    $547K
    award amount

Award organizations

Organizations that administered FY2023 awards listing Biediger, Ronald J as a PI.

Texas Heart Institute
TX
$1.1M
2 grants
Aviara Pharmaceuticals, Inc.
TX
$1M
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2022
    First NIH Award
    Texas Heart Institute
  2. 2022
    $500K Cumulative Funding
  3. 2023
    $1M Cumulative Funding
  4. 2023
    $2M Cumulative Funding
  5. 2023
    Entered Top 50% Nationally
    Ranked #3312
  6. 2023
    Entered Top 25% Nationally
    Ranked #3312
  7. 2023
    Multi-Institutional Research
    Awards at 2 institutions

Explore further

Find collaborators for Biediger, Ronald J

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →